Christopher Keel, DO
Urology · Fairhope, ALNPI 1619111200
Payments from drug & device makers
What this record shows
This record is dominated by education: $44,748 of the $67,666 with a category attached, or 66.1%. Intuitive Surgical accounts for 80.5% of it on its own, with 51 other manufacturers making up the rest. Reporting peaked in 2022 at $23,964 and has fallen 77.3% since, to $5,433 in 2025. Among urology clinicians in AL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 487 payments — averaging $138.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$54K
- Johnson & Johnson$5K
- Medtronic$2K
- AbbVie$719
- Antares Pharma, Inc.$517
- Myriad Genetic Laboratories, Inc.$447
- plus $5K from 46 others
Across 2 payments — averaging $6850.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Ferring Pharmaceuticals AS$14K
What the payments were for
- Speaking & faculty fees$3,6305%
- Travel & lodging$4,7107%
- Food & beverage$14,55422%
- Education$44,74866%
- Gifts$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$46,911
- DA VINCI SP$5,202
- RYBREVANT$3,778
- CARVYKTI$3,778
- INTERSTIM$407
- PROVENGE$156
- Prolaris$129
- SPACEOAR VUE$125
- 16 FR. FLEXIBLE VIDEO CYSTOSCOPE$123
- ALTIS$117
- N/A$112
- AMS 700$105
- UroLift$100
How this compares
$67,666 in reported general payments places this provider in the 95th percentile of 179 urology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Abiraterone Acetate | 23 | $49,751 |
| MyrbetriqMirabegron | 26 | $23,705 |
| GemtesaVibegron | 26 | $18,311 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 130 | $2,605 |
| Testosterone Cypionate | 50 | $2,169 |
| Finasteride | 74 | $984 |
| Tamsulosin Hcl | 83 | $889 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $308 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 29 | $289 |
| Cefdinir | 14 | $237 |
| Prednisone | 19 | $86 |
| Ondansetron Hcl | 11 | $78 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Janssen Scientific Affairs, LLCAbiraterone Acetate | $214 | $49,75123 claims |
| Astellas Pharma US IncMyrbetriq | $444 | $23,70526 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $212 | $18,31126 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 179 urology providers in Alabama.
Other urology in Fairhope
- Christopher PetrusFairhope$7K
- Thomas ChiBirmingham$463K
- Joel FunkBirmingham$347K
- Adam BaumgartenBirmingham$271K
- Brian ChristineHomewood$215K
- Vincent BivinsHomewood$117K
- Kyle WoodBirmingham$91K
- Rachel EngelbergHomewood$61K
- Jeffrey NixBirmingham$54K
- Tracey WilsonBirmingham$38K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.